Accord BioPharma received FDA approval for 420mg HERCESSI, a biosimilar to Herceptin to treat various kinds of ...

The agreement will allow Lupin to expand its gastroenterology portfolio in the Indian market. Credit: Orawan Pattarawimonchai ...

Gavi (the Global Alliance for Vaccines and Immunization) has entered an advance purchase agreement with Bavarian Nordic to ...

The US FDA has granted approval for MSD’s KEYTRUDA regimen as a first-line treatment for malignant pleural mesothelioma (MPM) ...

An innovative approach to healthcare, precision medicine is a new medical model that takes into account individual ...

Kisqali generated $2bn in sales last year, with broader approvals forecasting sales of over $8bn by 2030, per GlobalData ...

A single dose of Ixchiq induced a high and sustained immune response in 99.1% of adolescents, according to Valneva.

Members of the biotech industry have voiced concerns about the impact of the BIOSECURE Act, after the bill passed through the ...

Ossium Health’s PRESERVE I trial is evaluating the safety and effectiveness of its deep-frozen bone marrow from deceased ...

Japan's MHLW has accepted for review GSK's NDA for Blenrep for patients with relapsed or refractory multiple myeloma.

The Israeli Ministry of Health granted approval for BeiGene’s TEVIMBRA for unresectable or metastatic oesophageal squamous ...

Nura Bio has secured additional $68m in a Series A financing round to advance the development of its neuroprotective ...